High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India

References

1. Aarestrup F. M., Molbak K., Threlfall E. J. 2003; Is it time to change fluoroquinolone breakpoints for Salmonella spp.?. Antimicrob Agents Chemother 47:827–829 [CrossRef]
   [Google Scholar]
2. Brown J. C., Shanahan P. M., Jesudason M. V., Thomson C. J., Amyes S. G. 1996; Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J Antimicrob Chemother 37:891–900 [CrossRef]
   [Google Scholar]
3. Eykyn S. J., Williams H. 1987; Treatment of multiresistant Salmonella typhi with oral ciprofloxacin. Lancet ii:1407–1408
   [Google Scholar]
4. Harish B. N., Madhulika U., Parija S. C. 2004; Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp.enterica serotype Paratyphi A. J Med Microbiol 53:819– 819 [CrossRef]
   [Google Scholar]
5. Hirose K., Hashimoto A., Tamura K., Kawamura Y., Ezaki T., Sagara H., Watanabe H. 2002; DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob Agents Chemother 46:3249–3252 [CrossRef]
   [Google Scholar]
6. Jesudason M. V., Malathy B., John J. T. 1996; Trend of increasing minimum inhibitory concentration of ciprofloxacin to Salmonella typhi . Indian J Med Res 103:247–249
   [Google Scholar]
7. Kapil A., Sood S., Dash N. R., Das B. K., Seth P. 1999; Ciprofloxacin in typhoid fever. Lancet 354:164– 164
   [Google Scholar]
8. Kapil A., Renuka K., Das B. K. 2002; Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella typhi . Indian J Med Res 115:49–54
   [Google Scholar]
9. Launay O., Nguyen Van J. C., Buu-Hoi A., Acar J. F. 1997; Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones. Clin Microbiol Infect 3:541–544 [CrossRef]
   [Google Scholar]
10. Mandal B. K. 1991; Modern treatment of typhoid fever. J Infect 22:1–4 [CrossRef]
    [Google Scholar]
11. NCCLS 2002 Performance Standards for Antimicrobial Disc Susceptibility Tests , 7th edn. Approved standard M2-A7 Wayne, PA: NCCLS;
    [Google Scholar]
12. Renuka K., Kapil A., Kabra S. K., Wig N., Das B. K., Prasad V. V., Chaudhry R., Seth P. 2004; Reduced susceptibility to ciprofloxacin and gyrA gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A. Microb Drug Resist 10:146–153 [CrossRef]
    [Google Scholar]
13. Sanders C. C. 2001; Mechanisms responsible for cross-resistance and dichotomous resistance among quinolones. Clin Infect Dis 32:S1–S8 [CrossRef]
    [Google Scholar]
14. Wain J., Hoa N. T. T., Chinh N. T. & 8 other authors; 1997; Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 25:1404–1410 [CrossRef]
    [Google Scholar]